Leigh Hsu
Corporate Officer/Principal bij CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profiel
Leigh Hsu is a professional who currently holds the position of Senior Vice President-Business Development at CARsgen Therapeutics Holdings Ltd.
He has previously worked as Director-Business Development at ACADIA Pharmaceuticals, Inc. and as Vice President-Corporate Development & Strategy at Lpath, Inc. Dr. Hsu holds an MBA degree from the University of California, Irvine and a doctorate degree from the University of California San Diego.
Actieve functies van Leigh Hsu
| Bedrijven | Functie | Begin |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Corporate Officer/Principal | 01-06-2017 |
Eerdere bekende functies van Leigh Hsu
| Bedrijven | Functie | Einde |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Opleiding van Leigh Hsu
| University of California San Diego | Doctorate Degree |
| University of California, Irvine | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
